Stroma formation in Ehrlich carcinoma. I. Oedema phase. A mitosis burst as an index of physiological reoxygenation?
Tumor stroma induction has been shown closely to resemble wound repair process, both involving the replacement of a fibrin gel by vascularized connective tissue. In such a process the initial phase of hyperpermeability of blood vessels leads to diffuse oedema. It is here reported that cell loosening and a remarkably high mitotic burst were observed in Ehrlich carcinoma in regions in contact with the exudate, particularly at the perinecrotic (hypoxic) region. This suggests both an enhanced cell detachment from the tumour parenchyma and an improvement of the microenvironment, the exudate thus appearing as beneficial to the malignant cells contributing to the reoxygenation of formerly hypoxic regions. The temporary and well-localized concentration of mitoses in inner tumour areas has perhaps been disregarded by the pathologists engaged in mitosis counting for tumour grading. Peripheric and intraparenchymal concentrations of mast cells, lipid pools and platelets were seen in apparently key geometric disposition for controlling fibrin deposition and angiogenesis. Hypoxia is known to cause resistance to oxygen-dependent treatments and to facilitate cell detachment; normal fibroblasts respond and survive under hypoxic conditions by exhibiting features of the malignant phenotype. During reoxygenation, gene instability, cellular heterogeneity and increased drug resistance and metastatic spread have been reported. A reoxygenation process can also be deduced from several other histochemical and morphological patterns observed in this study. The findings here reported thus suggest that the oedema phase is a crucial phase regulating growth, invasion and dissemination of tumour cell populations, that should be specifically addressed therapeutically.
Freitas
I
I
Department of Animal Biology, University of Pavia, Italy.
Baronzio
G F
GF
Bertone
V
V
Griffini
P
P
Gerzeli
G
G
Pontiggia
P
P
Stoward
P J
PJ
D000818:Animals; D002286:Carcinoma, Ehrlich Tumor / Q000201:enzymology / Q000503:physiopathology*; D004487:Edema / Q000473:pathology* / Q000503:physiopathology; D005260:Female; D007770:L-Lactate Dehydrogenase / Q000032:analysis; D008407:Mast Cells / Q000473:pathology; D051379:Mice; D008856:Microscopy, Fluorescence; D008938:Mitosis; D009336:Necrosis; D010101:Oxygen Consumption; D013194:Staining and Labeling; D014617:Vacuoles / Q000648:ultrastructure
D007770:L-Lactate Dehydrogenase